Avicanna Announces Closing of Acquisition and Launch of MyMedi.ca
01 August 2023 - 1:30PM
Avicanna Inc. (“
Avicanna” or the
“
Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a
biopharmaceutical company focused on the development,
manufacturing, and commercialization of plant-derived
cannabinoid-based products is pleased to announce it has closed of
the previously announced acquisition of the Medical Cannabis by
Shopper’s Business (“
Business”) from Shoppers Drug
Mart® and pleased to announce the launch of an all-new medical
cannabis care platform, MyMedi.ca.
Today, MyMedi.ca, a medical cannabis care
platform, has officially launched nationwide in Canada. The
platform's features include:
- Medical Cannabis
Marketplace: A diverse medical cannabis marketplace
featuring approximately 200 unique products supplied by a network
of 35 brands from various leading Canadian licensed producers.
- Pharmacist-Led Patient Care
Services: Pharmacist-led fully bilingual (English and
French) patient care service programs including pharmacovigilance,
compassionate pricing, and insurance adjudication in compliance
with standards established by private and public payers.
- Patient Education:
Patient education programs and informational resources, including
harm reduction strategies and risk mitigation.
- Education for Healthcare
Professionals: Medical education, training, and resources
available to health care practitioners, hospitals, clinics, and
institutions, along with potential collaboration opportunities,
through the Company’s Medical Affairs department
“We are pleased to have closed the acquisition
of the Business from Shoppers Drug Mart® and recognize this as a
transformational milestone in the life of our Company. We would
like to express our gratitude to the incredible network of
collaborators who came together to ensure a smooth transition for
the patients and deliver this medical platform that is adhering to
required standards of patient privacy and care. We are motivated to
meet the needs of our new patients through MyMedi.ca and welcome
the thousands of patients that have transitioned over from the
Medical Cannabis by Shoppers platform,” stated Aras Azadian, CEO of
Avicanna.
About Avicanna Inc.
Avicanna is a commercial-stage international
biopharmaceutical company focused on the advancement and
commercialization of evidence-based cannabinoid-based products for
the global medical and pharmaceutical market segments. Avicanna has
an established scientific platform including R&D and clinical
development that has led to the commercialization of more than
thirty products across various market segments:
- Medical Cannabis &
Wellness Products (RHO
Phyto™): The
formulary offers a diverse range of proprietary formulations
including oral, sublingual, topical, and transdermal deliveries
with varying ratios of cannabinoids and is supported with ongoing
patient, and medical community education. RHO Phyto has been
established as a leading medical brand in Canada and is currently
available nationwide to patients across several medical channels
and continues to expand into new international markets.
- Pharmaceutical Preparations
and Pipeline: Leveraging Avicanna’s
scientific platform, vertical integration, and real-world evidence,
Avicanna has developed an extensive a pipeline of patent-pending
drug candidates that are indication-specific and in various stages
of clinical development and commercialization. These
cannabinoid-based drug candidates look to address unmet medical
needs in the areas of dermatology, chronic pain, and various
neurological disorders. Avicanna’s first pharmaceutical preparation
(Trunerox™) is in the drug registration stage in South
America.
- MyMedi.ca
Medical Cannabis Care: MyMedi.ca
is Avicanna’s medical cannabis care platform that is formed with
the aim to better serve medical cannabis patients’ needs and
enhance the patient journey. MyMedi.ca features diverse and
scientifically curated products from leading Canadian licensed
producers in addition to pharmacist led patient support programs
and educational resources to facilitate the incorporation of
medical cannabis into health care regimens. MyMedi.ca also provides
specialty services to distinct patient groups such as veterans and
collaborating with public and private providers for adjudication
and reimbursement.
Click to watch Avicanna’s Corporate Video 2022
SOURCE Avicanna Inc.
Stay Connected
For more information about Avicanna, visit our
website, contact Ivana Maric by email at info@avicanna.com or
follow us on social media
on LinkedIn, Twitter, Facebook, or Instagram.
The Company posts updates through videos from
the Company YouTube channel.
Cautionary Note Regarding Forward-Looking Information
and Statements
This news release contains “forward-looking
information” within the meaning of applicable securities laws.
Forward-looking information contained in this news release may be
identified using words such as, “may”, “would”, “could”, “will”,
“likely”, “expect”, “anticipate”, “believe, “intend”, “plan”,
“forecast”, “project”, “estimate”, “outlook” and other similar
expressions. Although the Company believes that the expectations
and assumptions on which such forward looking information is based
are reasonable, undue reliance should not be placed on the
forward-looking information because the Company can give no
assurance that they will prove to be correct. Actual results and
developments may differ materially from those contemplated by these
statements. Forward-looking information is subject to a variety of
risks and uncertainties that could cause actual events or results
to differ materially from those projected in the forward-looking
information. Such risks and uncertainties include but are not
limited to current and future market conditions, including the
market price of the common shares of the Company, and the risk
factors set out in the Company’s annual information form dated
March 31, 2023 filed with the Canadian securities regulators and
available under the Company’s profile on SEDAR at www.sedar.com.
The statements in this news release are made as of the date of this
release. The Company disclaims any intent or obligation to update
any forward-looking information, whether as a result of new
information, future events or results or otherwise, other than as
required by applicable securities laws.
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/ddd63440-3166-4827-879b-b327f0c70476
Avicanna (TSX:AVCN)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Avicanna (TSX:AVCN)
Historical Stock Chart
Von Mai 2023 bis Mai 2024